Cost-minimization analysis of individually tailored or fixed-scheduled rituximab maintenance therapy for antineutrophil-cytoplasm antibody associated vasculitides

Cost-minimization analysis of individually tailored or fixed-scheduled rituximab maintenance therapy for antineutrophil-cytoplasm antibody associated vasculitides

Objective: Patients included in MAINRITSAN2 trial received either an individually tailored or a fixed-schedule therapy with rituximab as maintenance treatment of antineutrophil cytoplasm antibody associated vasculitides. The aim of this study was to compare the real-world costs of both arms. Meth...

Full description

Saved in:
Bibliographic Details
Main Authors: Ana Belén Guisado-Gil, Marina Muñoz-Burgos, Ana Ortega-Eslava, Francisco Javier García-Hernández, Bernardo Santos-Ramos
Format: Article
Language:English
Published: Elsevier 2020-03-01
Series:Farmacia Hospitalaria
Subjects:
rituximab
antibodies
antineutrophil cytoplasmic
anca associated vasculitides
pharmacoeconomy
Online Access:http://www.aulamedica.es/fh/pdf/11287.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.aulamedica.es/fh/pdf/11287.pdf

Similar Items